ROLE OF GSTM AND GSTT POLYMORPHIC GENES IN ONCOGENESIS AND THE ONSET OF HEMATOLOGIC NEOPLASMS
##article.numberofdownloads## 61
##article.numberofviews## 133
PDF (Русский)

Keywords

REVIEW
BIOTRANSFORMATION OF XENOBIOTICS
GLUTATHIONE-S-TRANSFERASE
GENETIC POLYMORPHISMS
TUMORIGENESIS
THE HEMATOLOGICAL MALIGNANCIES

How to Cite

Karimov, K., & Assesorova, Y. (2020). ROLE OF GSTM AND GSTT POLYMORPHIC GENES IN ONCOGENESIS AND THE ONSET OF HEMATOLOGIC NEOPLASMS. Voprosy Onkologii, 66(5), 472–478. https://doi.org/10.37469/0507-3758-2020-66-5-472-478

Abstract

Throughout life, a person is exposed to various xenobiotics, one of the biological effects of which is the genotoxic effect, leading to the occurrence of oncogenic mutations. Mutagenic and promutagenic substances can be detoxified with the corresponding xenobiotic biotransformation enzymes, however, if the enzymatic activity of the latter changes, the neutralization of the mutagens occurs at a slower pace. The review discusses the polymorphic genes of enzymes of the second phase of the biotransformation of xenobiotics of the GSTS family and presents modern literature data on the role of GSTM and GSTT in oncogenesis and the development of hemoblastoses. The search of scientific literature was carried out using the PubMed and СyberLeninka databases.
https://doi.org/10.37469/0507-3758-2020-66-5-472-478
##article.numberofdownloads## 61
##article.numberofviews## 133
PDF (Русский)

References

Berger A.H., Knudson A.G., Pandolfi P.P. A continuum model for tumour suppression // Nature. - 2011. - Vol. 476 (7359). - Р 163-169.

Wang L.H., Wu C.F., Rajasekaran N., Shin Y.K. Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview // Cell Physiol Biochem. - 2018. - Vol. 51 (6). - Р 2647-2693.

Чурносов М.И., Полякова И.С., Пахомов С.П., Орлова В.С. Молекулярные и генетические механизмы биотрансформации ксенобиотиков // Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. - 2011. - Т 15 (16 (111)). - С. 223-228.

Могиленкова Л.А., Рембовский В.Р Роль генетического полиморфизма и различия в детоксикации химических веществ в организме человека // Гигиена и санитария. - 2016. - Т. 95 (3). - С. 255-262. - doi: 10.18821/0016-9900-2016-95-3-255-262.

Корчагина Р.П., Осипова Л.П., Вавилова Н.А. и др. Полиморфизм генов биотрансформации ксенобиотиков GSTM1, GSTT1, CYP2D6, вероятных маркеров риска онкологических заболеваний, в популяциях коренных этносов и русских северной Сибири // Вавиловский журнал генетики и селекции. - 2011. - Т. 15. - № 3. - C. 448-461.

Gong M., Dong W., Shi Z. et al. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies // PLoS One. - 2012. - Vol. 7 (11). - e50587. - doi: 10.1371/journal. pone.0050587.

Klusek J., G uszek S., Klusek J. GST gene polymorphisms and the risk of colorectal cancer development // Contemp Oncol (Pozn). - 2014. - Vol. 18 (4). - P 219-221. - doi: 10.5114/wo.2014.41388.

Pljesa-Ercegovac M., Matic M. GSTM1 (Glutathione Transferase M1) // Atlas Genet Cytogenet Oncol Haematol. - 2016. - Vol. 20 (1). - P 7-13. - https://doi. org/10.4267/2042/62504.

Lo H.W., Ali-Osman F. Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance // Curr Opin Pharmacol. - 2007. - Vol. 7 (4). - P 367374. - doi: 10.1016/j.coph.2007.06.009.

Wu W., Peden D., Diaz-Sanchez D. Role of GSTM1 in resistance to lung inflammation // Free Radic Biol Med. - 2012. - Vol. 53 (4). - P. 721-729. - doi: 10.1016/j.freeradbiomed.2012.05.037.

Piacentini S., Polimanti R., Porreca F. et al. GSTT1 and GSTM1 gene polymorphisms in European and African populations // Mol Biol Rep. - 2011. - Vol. 38 (2). - P 1225-1230. - doi: 10.1007/s11033-010-0221-0.

Garte S., Gaspari L., Alexandrie A.K. et al. Metabolic gene polymorphism frequencies in control populations // Cancer Epidemiology Biomarkers & Prevention. - 2001. - Vol. 10. - P. 1239-1248. - https://cebp.aacrjour-nals.org/content/cebp/10/12/1239.full.pdf.

Фетисова И.Н., Межинский С.С., Чаша Т.В. и др. Полиморфизм генов системы детоксикации // Вестник ИвМА. - 2014. - Т. 19. - № 4. - С. 50-58.

He F., Liu C., Zhang R. et al. Association between the Glutathione-S-transferase T1 null genotype and esophageal cancer susceptibility: a meta-analysis involving 11,163 subjects // Oncotarget. - 2018. - Vol. 9 (19). - P 15111-15121. - doi: 10.18632/oncotarget.24534.

Adibhesami G., Shahsavari G.R., Amiri A. et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) Polymorphisms and Lung Cancer Risk among a Select Group of Iranian People // Asian Pac J Cancer Prev. - 2018. - Vol. 19 (10). - P 2921-2927. - doi: 10.22034/APJCP2018.19.10.2921.

Yu P, Kusuma J.D., Suarez M.A.R., Shiao S.PK. Correction: Lung cancer susceptibility from GSTM1 deletion and air pollution with smoking status: a meta-prediction of worldwide populations // Oncotarget. - 2018. - Vol. 9 (90). - P 36251. - doi: 10.18632/oncotarget.26388.

Chen D.K., Huang W.W., Li L.J. et al. Glutathione S-trans-ferase M1 and T1 null genotypes and bladder cancer risk: A meta-analysis in a single ethnic group // J Cancer Res Ther. - 2018. - Vol. 14 (Supplement). - S993-S997. - doi: 10.4103/0973-1482.191067.

Albarakati N., Khayyat D., Dallol A. et al. The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer // BMC Cancer. - 2019. - Vol. 19 (1). - P 991. - doi: 10.1186/s12885-019-6244-6.

Safarinejad M.R., Shafiei N., Safarinejad S.H. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran // Prostate Cancer Prostatic Dis. - 2011. - Vol. 14 (2). - P. 105-113. - doi: 10.1038/ pcan.2010.54.

Economopoulos K.P, Sergentanis T.N. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis // Eur J Cancer. - 2010. - Vol. 46 (9). - P. 1617-1631. - doi: 10.1016/j.ejca.2010.02.009.

Darazy M., Balbaa M., Mugharbil A. et al. CYP1A1, CY-P2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese // Genet Test Mol Biomarkers. - 2011. - Vol. 15 (6). - P 423-429. - doi: 10.1089/gtmb.2010.0206.

Wang B., Huang G., Wang D. et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis // J Hepatol. - 2010. - Vol. 53 (3). - P. 508-518. - doi: 10.1016/j.jhep.2010.03.026.

Liu K., Zhang L., Lin X. et al. Association of GST genetic polymorphisms with the susceptibility to hepatocellular carcinoma (HCC) in Chinese population evaluated by an updated systematic meta-analysis // PLoS One. - 2013. - Vol. 8 (2). - e57043. - doi: 10.1371/journal. pone.0057043.

Zhang Z.J., Hao K., Shi R. et al. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis // Am J Epidemiol. - 2011. - Vol. 173 (8). - P. 847-857. - doi: 10.1093/aje/kwq480.

Li J.Y, Huang L.N., Xue H.L. et al. Glutathione S-transferase mu-1, glutathione S-transferase theta-1 null genotypes, and oral cancer risk: A meta-analysis in the Chinese population // J Cancer Res Ther. - 2018. - Vol. 14 (Supplement). - S1052-S1056. - doi: 10.4103/09731482.199786.

D’ Mello S., Bavle R.M., Paremala K. et al. The synergy of tobacco and alcohol and glutathione S-transferase 0 1 gene deletion and oral squamous cell carcinoma // J Oral Maxillofac Pathol. - 2016. - Vol. 20 (3). - P. 348-353. - doi: 10.4103/0973-029X.190898.

Wang J., Wu D., Sun A. Effects of GST null genotypes on individual susceptibility to leukemia: A meta-analysis // Exp Mol Pathol. - 2019. - Vol. 108. -P. 137-142. - doi: 10.1016/j.yexmp.2019.01.004.

Chen H.C., Hu W.X., Liu Q.X. et al. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility // Eur J Cancer Prev. - 2008. - Vol. 17 (3). - P. 251-258. - doi: 10.1097/CEJ.0b013e3282b72093.

He H.R., You H.S., Sun J.Y et al. Glutathione S-transfer-ase gene polymorphisms and susceptibility to acute myeloid leukemia: meta-analyses // Jpn J Clin Oncol. - 2014. - Vol. 44 (11). - P. 1070-1081. - doi: 10.1093/ jjco/hyu121.

Gra O.A., Glotov A.S., Nikitin E.A., et al. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin’s lymphoma in adult Russian patients // Am. J. Hematol. - 2008. - Vol. 83 (4). - P. 279-287. - doi: 10.1002/ajh.21113.

Овсепян В.А., Росин В.А., Загоскина Т.П., Дьяконов Д.А. Полиморфизм генов CYP1A1, GSTM1, GSTT1 и GSTP1 и некоторые клинико-лабораторные проявления хронического лимфолейкоза // Гематол. и трансфузиол. - 2013. - Т 58. - № 2. - С. 22-28.

Bajpai P., Tripathi A.K., Agrawal D. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia // Leuk Res. - 2007. - Vol. 31 (10). - P. 13591363. - doi: 10.1016/j.leukres.2007.02.003.

Ozten N., Sunguroglu A. Bosland M.C. Variations in glutathione-S-transferase genes influence risk of chronic myeloid leukemia // Hematol Oncol. - 2012. - Vol. 30 (3). - P. 150-155. - doi: 10.1002/hon.1018.

Muddathir A.R.M., Abdallah E.I., Khabour O.F. et al. Age-and gender-independent association of glutathione-S-transferase null polymorphisms with chronic myeloid leukemia // Bosn J Basic Med Sci. - 2019. - Vol. 19 (4). - P. 350-354. - doi: 10.17305/bjbms.2019.4176.

Rostami G., Assad D., Ghadyani F. et al. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response // Mol Genet Genomic Med. - 2019. - Vol. 7 (7). - e00717. - doi: 10.1002/mgg3.717.

Zhao T., Ma F., Yin F. Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in childhood acute lymphoblastic leukemia risk: an updated meta-analysis // Minerva Pediatr. - 2018. - Vol. 70 (2). - P. 185-196. - doi: 10.23736/S0026-4946.17.04657-6.

Zehra A., Zehra S., Ismail M., Azhar A. Glutathione S-Transferase M1 and T1 Gene Deletions and Susceptibility to Acute Lymphoblastic Leukemia (ALL) in adults // Pak J Med Sci. - 2018. - Vol. 34 (3). - P. 666-670. - doi: 10.12669/pjms.343.14911.

Farasani A. Genetic variants of glutathione S-transferase and the risk of acute myeloid leukemia in a Saudi population // Saudi J Biol Sci. - 2019. - Vol. 26 (7). - P. 1525-1530. - doi: 10.1016/j.sjbs.2018.12.011. Al-Achkar W., Azeiz G., Moassass F., Wafa A. Influence of CYP1A1, GST polymorphisms and susceptibility risk of

Salinas-Sanchez A.S., Sanchez-Sanchez F., Donate-More-no M.J. et al. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer // BJU Int. - 2011. - Vol. 107 (11). - P. 1825-1832. - doi: 10.1111/j.1464-410X.2010.09683.x.

Safarinejad M.R., Safarinejad S., Shafiei N., Safarinejad S. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility // Urol Oncol. - 2013. Vol. 31 (7). - P. 1193-203. - doi: 10.1016/j.urolonc.2011.11.027.

Liu D., Liu Y, Ran L. et al. GSTT1 and GSTM1 polymorphisms and prostate cancer risk in Asians: a systematic review and meta-analysis // Tumour Biol. - 2013. - Vol. (5). - P. 2539-2544. - doi: 10.1007/s13277-013-0778-z.

Martnez C., Martn F., Fernndez J.M. et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans // Pharmacoge-nomics. - 2006. - Vol. 7 (5). - P. 711-718. - doi: 10.2217/14622416.7.5.711.

Saxena A., Dhillon V.S., Raish M. et al. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population // Breast Cancer Res Treat. - 2009. - Vol. 115 (3). - P. 537-543. - doi: 10.1007/s10549-008-0098-y.

Sergentanis T.N., Economopoulos K.P. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis // Breast Cancer Res Treat. - 2010. - Vol. 121 (1). - P. 195-202. - doi: 10.1007/s10549-009-0520-0.

Saravani S., Miri-Moghaddam M., Bazi A., Miri-Moghad-dam E. Association of Glutathione-S-Transferases M1 and T1 Deletional Variants with Development of Oral Squamous Cell Carcinoma: A Study in the South-East of Iran // Asian Pac J Cancer Prev. - 2019. - Vol. 20 (6). - P. 1921-1926. - doi: 10.31557/APJCP.2019.20.6.1921.

Ntais C., Polycarpou A., Ioannidis J.P. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis // Cancer Epidemiol Biomarkers Prev. - 2005. - Vol. 14 (1). - P. 176-181. - Available at: https://cebp.aacrjournals. org/content/14/1/176.full-text.pdf.

Garc a-Gonzlez M.A., Quintero E., Bujanda L. et al. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype // Mutagenesis. - 2012. - Vol. 27 (6). - P. 771-777. - doi: 10.1093/mutage/ges049.

Matic M., Pekmezovic T., Djukic T. et al. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study // Urol Oncol. - 2013. - Vol. 31 (7). - P. 1184-1192. - 49 doi: 10.1016/j.urolonc.2011.08.005. chronic myeloid leukemia in Syrian population // Med Oncol. - 2014. - Vol. 31 (5). - P. 889. - doi: 10.1007/ s12032-014-0889-4.

Weich N., Ferri C., Moiraghi B. et al. GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response // Cancer Epidemiol. - 2016. - Vol. 44. - P. 16-21. - doi: 10.1016/j.canep.2016.07.008.

Bhat G., Bhat A., Wani A. et al. Polymorphic variation in glutathione-S-transferase genes and risk of chronic myeloid leukaemia in the Kashmiri population // Asian Pac J Cancer Prev. - 2012. - Vol. 13 (1). - P. 69-73. - doi: 10.7314/apjcp.2012.13.1.069.

Kassogue Y, Dehbi H., Quachouh M. et al. Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia // Springerplus. - 2015. - Vol. 4. - P. 210. - doi: 10.1186/s40064-015-0966-y.

Ovsepyan V.A., Tregubova E.V., Luchinin A.S., Minaeva N.V. Gene Polymorphism of Xenobiotic Biotransformation Enzymes in Patients with Classical Ph-Negative Myeloproliferative Neoplasms // Bull Exp Biol Med. - 2019. - Vol. 167 (6). - P. 767-770. - doi: 10.1007/s10517-019-04619-5.

Banescu C., Iancu M., Trifa A.P. et al. From Six Gene Polymorphisms of the Antioxidant System, Only GPX Pro-198Leu and GSTP1 Ile105Val Modulate the Risk of Acute Myeloid Leukemia // Oxid Med Cell Longev. - 2016. - Vol. 2016. - P. 2536705. - doi: 10.1155/2016/2536705.

Nasr A.S., Sami R.M., Ibrahim NY, Darwish D.O. Glutathione S transferase (GSTP 1, GSTM 1, and GSTT 1) gene polymorphisms in Egyptian patients with acute myeloid leukemia // Indian J Cancer. - 2015. - Vol. 52 (4). - P. 490-495. - doi: 10.4103/0019-509X.178408.

Das P., Shaik A.P., Bammidi V.K. Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT 1) gene polymorphisms and risk of acute myeloid leukemia // Leuk Lymphoma. - 2009. - Vol. 50 (8). - P. 1345-1351. - doi: 10.1080/10428190903003236.

Davies S.M., Robison L.L., Buckley J.D. et al. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children’s Cancer Group study // Cancer Epidemiol Biomarkers Prev. - 2000. - Vol. 9 (6). - P. 563-566. - Available at: https://cebp.aacrjournals. org/content/9/6/563.full-text.pdf.

Joseph T, Kusumakumary P., Chacko P. et al. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT 1 and susceptibility to acute lymphoblastic leukaemia in Indian children // Pediatr Blood Cancer. - 2004. - Vol. 43 (5). - P. 560-567. - doi: 10.1002/pbc.20074.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2020